Spots Global Cancer Trial Database for clear cell component
Every month we try and update this database with for clear cell component cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial | NCT01217931 | Kidney Cancer | Pazopanib Bevacizumab Everolimus | 18 Years - | M.D. Anderson Cancer Center |